Detalhe da pesquisa
1.
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
Lancet Haematol
; 9(5): e340-e349, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344689